Biotech - Press Releases

Date	Title	Company
23-Sep-2020	Aqilion announces identity of drug target and presents novel data from the drug discovery program Alnitak	Aqilion
23-Sep-2020	Interim results for the six months ended 30 June 2020 Strong performance from Consumer Healthcare brands; cash generation remains robust; full year results tracking in line with market expectations	ALLIANCE PHARMA PLC
23-Sep-2020	Nemaura Medical Licenses Validated Mobile Application to Create Powerful Diabetes Prevention and Management Suite of Products	Nemaura Medical, Inc.
23-Sep-2020	Aqualung Therapeutics Corp. Awarded $300K from NIH to Develop A Novel Therapeutic For Pregn	Aqualung Therapeutics
23-Sep-2020	Janssen Presents Findings from Global, Multi-Centre Trial Examining Amivantamab in Combination with Lazertinib in Patients with EGFR-Mutated Non-Small Cell Lung Cancer	The Janssen Pharmaceutical Companies of Johnson & Johnson
23-Sep-2020	Lynparza recommended for approval in EU by CHMP as 1st-line maintenance treatment with bevacizumab for HRD-positive advanced ovarian cancer	AstraZeneca
23-Sep-2020	Lynparza recommended for approval in the EU by CHMP for BRCA-mutated metastatic castration-resistant prostate cancer	AstraZeneca
23-Sep-2020	Lynparza reduced the risk of death by 31% in BRCA1/2 or ATM-mutated metastatic castration-resistant prostate cancer in PROfound Phase III trial	AstraZeneca
23-Sep-2020	Switching to investigational once-weekly insulin icodec from other basal insulins demonstrated to be efficacious and well-tolerated for people with type 2 diabetes in phase 2 trial	Novo Nordisk
23-Sep-2020	Preliminary Results for the year ended 30 June 2020	Allergy Therapeutics plc
23-Sep-2020	PureTech Plans U.S. Listing on Nasdaq Global Market	PureTech Health
23-Sep-2020	Helsinn supports the PhD program 2020-2021 of the Institute of Oncology Research (IOR) of the Faculty of Biomedical Sciences at the Università della Svizzera italiana (USI)	Helsinn
23-Sep-2020	UCB Achieves Important Regulatory Milestone for Bimekizumab	UCB
23-Sep-2020	Thomas International launches new Talent Assessment Platform	Thomas International
23-Sep-2020	Pain Management Drugs Market to Reach $85.54 Bn, Globally, by 2027 at 3.9% CAGR: Allied Market Research	Allied Market Research
23-Sep-2020	Neurelis Announces Program To Investigate The Safety And Pharmacokinetics Of VALTOCO® (Diazepam Nasal Spray) In Children Aged 2 To 5	Neurelis, Inc.
23-Sep-2020	Neurelis Announces Program To Investigate The Safety And Pharmacokinetics Of VALTOCO® (Diazepam Nasal Spray) In Children Aged 2 To 5	Neurelis, Inc.
23-Sep-2020	Ardigen has received funding to accelerate its AI-driven TCR discovery platform for novel cell therapies	Ardigen SA
23-Sep-2020	Collagen Market Worth $7.53 Billion by 2027- Exclusive Report Covering Pre and Post COVID-19 Market Analysis by Meticulous Research®	Meticulous Market Research Pvt. Ltd
23-Sep-2020	New Study Indicates that KUBTEC's Mozart® 3D Specimen Imaging Decreases Re-Excision Rates for Breast Lumpectomies By More Than 50%	Kubtec